Treprostinil Diolamine
Brand name: Orenitram Er
Rank #209 of 500 drugs by total cost
$68.2M
Total Cost
5,964
Total Claims
$68.2M
Total Cost
165
Prescribers
$11K
Cost per Claim
60
Beneficiaries
5,994
30-Day Fills
$413K
Avg Cost/Provider
36
Avg Claims/Provider
About Treprostinil Diolamine
Treprostinil Diolamine (sold as Orenitram Er) was prescribed 5,964 times by 165 Medicare Part D providers in 2023, costing the program $68.2M. At $11K per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 206 | Prednisolone Acetate (Prednisolone Acetate) | $68.8M | 1,486,663 |
| 207 | Tenofovir Alafenamide (Vemlidy) | $68.7M | 44,509 |
| 208 | Abaloparatide (Tymlos) | $68.4M | 24,417 |
| 209 | Treprostinil Diolamine (Orenitram Er) | $68.2M | 5,964 |
| 210 | Esomeprazole Magnesium (Esomeprazole Magnesium) | $66.3M | 964,193 |
| 211 | Dabigatran Etexilate Mesylate (Dabigatran Etexilate) | $66.0M | 220,652 |
| 212 | Netarsudil Mesylate (Rhopressa) | $65.6M | 129,116 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology